435
Views
13
CrossRef citations to date
0
Altmetric
Review

Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion

, , , , , , , , & show all
Pages 1021-1033 | Published online: 19 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Fernando González-Torralba, Adolfo Baloira, Araceli Abad, Antonia Fuster, Juan Luis García-Rivero, Patricia García-Sidro, Eduardo Márquez-Martín, Marta Palop, Néstor Soler & José Luis Velasco. (2022) FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1005-1015.
Read now
Fiammetta Danzo, Dejan Radovanovic, Marina Gatti, Marina Saad, Luca Perotto, Elisa Franceschi & Pierachille Santus. (2022) A reappraisal of inspiratory capacity in chronic obstructive pulmonary disease: clinical correlates and role of long-acting muscarinic antagonists and long-acting β2 agonists. Expert Review of Respiratory Medicine 16:6, pages 623-635.
Read now

Articles from other publishers (11)

Xiuhua A. Si, Mohamed Talaat & Jinxiang Xi. (2023) Effects of guiding vanes and orifice jet flow of a metered-dose inhaler on drug dosimetry in human respiratory tract. Experimental and Computational Multiphase Flow 5:3, pages 247-261.
Crossref
Heba Banat, Rita Ambrus & Ildikó Csóka. (2023) Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance. International Journal of Pharmaceutics 643, pages 123070.
Crossref
Yu-Chung Hsu, Hsin-Hsien LiLi-Chung ChiuWen-Chieh ChiangTien-Pei FangHui-Ling Lin. (2023) Predicting Inhaled Drug Dose Generated by Mesh Nebulizers. Journal of Aerosol Medicine and Pulmonary Drug Delivery.
Crossref
Tamas Erdelyi, Zsofia Lazar, Árpád Farkas, Peter Furi, Attila Nagy & Veronika Müller. (2023) Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study. Frontiers in Medicine 10.
Crossref
Jennifer A. O'Neil & Larry A. Villasmil-Urdaneta. (2023) A path forward in the development of new aerosol drug delivery devices for pediatrics. Respiratory Medicine 211, pages 107210.
Crossref
Yanru Chen, Wei Chen, Xiaowen Xiang, Lianfu Deng, Jihong Qian, Wenguo Cui & Hao Chen. (2023) Pollen‐Inspired Shell–Core Aerosol Particles Capable of Brownian Motion for Pulmonary Vascularization. Advanced Materials 35:13.
Crossref
Mariam Chaoui, Sophie Perinel-Ragey, Nathalie Prévôt, Lara Leclerc & Jérémie Pourchez. (2022) Technical features of vaping drug delivery system for bronchodilator delivery. International Journal of Pharmaceutics 628, pages 122350.
Crossref
Riya Mahar, Arpita Chakraborty & Nidhi Nainwal. (2022) The influence of carrier type, physical characteristics, and blending techniques on the performance of dry powder inhalers. Journal of Drug Delivery Science and Technology 76, pages 103759.
Crossref
Kazunori Kadota, Koichi Matsumoto, Hiromasa Uchiyama, Satoshi Tobita, Munehiro Maeda, Daisuke Maki, Yuhei Kinehara, Isao Tachibana, Tomasz R. Sosnowski & Yuichi Tozuka. (2022) In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease. European Journal of Pharmaceutics and Biopharmaceutics 174, pages 10-19.
Crossref
Jeffry Weers. (2022) Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?. Frontiers in Drug Delivery 2.
Crossref
V. V. Arkhipov. (2021) Respimat as the new standard for inhalation therapy devices. Meditsinskiy sovet = Medical Council:16, pages 32-37.
Crossref